Detalhe da pesquisa
1.
STEMI: Considerations for Left Main Culprit Lesions.
Curr Cardiol Rep
; 24(6): 645-651, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35384548
2.
Strategies for drug-eluting stent treatment of bifurcation coronary artery disease in the United States: insights from the e-Cypher S.T.L.L.R.trial.
Catheter Cardiovasc Interv
; 73(7): 890-7, 2009 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19455662
3.
Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial.
Circulation
; 109(16): 1948-54, 2004 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-15078794
4.
Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy).
Am J Cardiol
; 96(4): 500-5, 2005 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16098300
5.
Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).
Am J Cardiol
; 93(9): 1092-6, 2004 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15110198
6.
Temporal spectrum of ischemic complications with percutaneous coronary intervention: the ESPRIT experience.
J Invasive Cardiol
; 16(9): 475-81, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15353828
7.
Are the results of a regional ST-elevation myocardial infarction system reproducible?
Am J Cardiol
; 109(11): 1582-8, 2012 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22440120